| Followers | 42 |
| Posts | 4316 |
| Boards Moderated | 0 |
| Alias Born | 07/14/2010 |
Thursday, November 04, 2021 9:41:41 AM
Recent ARTL News
- Artelo Biosciences Announces Publication of New Peer-Reviewed Study Demonstrating Intraperitoneal Administration of a Novel Fatty Acid Binding Protein 5 (FABP5) Inhibitor Significantly Reduces Stress-Induced Anxiety and Depression Behaviors in Preclinical • GlobeNewswire Inc. • 12/03/2025 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/03/2025 05:15:09 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/25/2025 09:05:41 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 11/17/2025 09:56:08 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2025 01:01:01 PM
- Artelo Biosciences Provides Business Update and Reports Third Quarter 2025 Financial Results • GlobeNewswire Inc. • 11/12/2025 01:00:00 PM
- Artelo Biosciences Announces Publication of Peer-Reviewed Article on Role of Fatty Acid Binding Proteins in Cancer • GlobeNewswire Inc. • 11/04/2025 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 12:00:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/27/2025 12:00:51 PM
- Artelo Biosciences Names Veteran Life Sciences Executive Mark Spring, CPA, as Chief Financial Officer • GlobeNewswire Inc. • 10/27/2025 12:00:00 PM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 10/21/2025 09:48:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/17/2025 08:30:34 PM
- Artelo Biosciences Announces Expanded Clinical Data to be Presented on both ART26.12 and ART27.13 at the 8th Annual Cannabinoid & Endocannabinoid Drug Development Summit • GlobeNewswire Inc. • 10/15/2025 01:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/01/2025 09:28:39 PM
- Artelo Biosciences Announces Closing of $2.0 Million Public Offering • GlobeNewswire Inc. • 10/01/2025 08:05:00 PM
- Artelo Biosciences Announces Pricing of $2.0 Million Public Offering • GlobeNewswire Inc. • 09/30/2025 12:30:00 PM
- Artelo Biosciences Announces Proposed Underwritten Public Offering • GlobeNewswire Inc. • 09/29/2025 11:15:00 PM
- Artelo Biosciences Announces Presentation of Positive Interim Phase 2 CAReS Data on ART27.13 at the 2025 Cancer Cachexia Society Conference • GlobeNewswire Inc. • 09/29/2025 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/15/2025 08:15:31 PM
- Artelo Biosciences Announces Publication of Preclinical Data Demonstrating Superior Efficacy and Bioavailability of ART12.11 in Reducing Stress-Induced Depression and Anxiety Symptoms • GlobeNewswire Inc. • 09/10/2025 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/10/2025 12:00:37 PM
Momentum Builds, Upside Appears as Mining Explorers Transition Toward Production, Unlock Major Hidden Value • B • Dec 8, 2025 9:00 AM
HealthLynked Appoints Duncan McGillivray as Chief Operating Officer to Accelerate National Expansion and Nasdaq Uplisting Strategy • HLYK • Dec 8, 2025 8:00 AM
Breakthrough Therapies Advance as Rare Disease Burden Intensifies Across Aging Populations • SNGX • Dec 4, 2025 10:18 AM
I-ON Digital Corp. Deploys $200 Million in Assets Under Management (AUM), Backed By In Situ Gold Reserves, As I-ON's Treasury Solidifies Diversified Yield Strategies From Digital Asset Deployment • IONI • Dec 4, 2025 8:30 AM
Metavesco Fast-Tracks OTC Prediction Market Platform • MVCO • Dec 3, 2025 9:12 AM
Scientists Pointing to Hidden Power Source That Could Reshape Future of AI • MAXXF • Dec 3, 2025 9:00 AM
